热门资讯> 正文

Abivax报告1H结果

2026-09-22 04:09

Abivax press release (ABVX): 1H
The Company had cash, cash equivalents and short-term investments of €402.4 million as of June 30, 2026.

More on Abivax

Abivax: Obefazimod Goes The Distance And So Does My Buy Rating
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Data in Ulcerative Colitis - Slideshow
Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play
Abivax raises $920M as underwriters fully exercise overallotment option
Abivax SA prices upsized $800M ADS offering

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。